Annual EBITDA:
$583.00M+$225.00M(+62.85%)Summary
- As of today, NBIX annual EBITDA is $583.00 million, with the most recent change of +$225.00 million (+62.85%) on December 31, 2024.
- During the last 3 years, NBIX annual EBITDA has risen by +$444.90 million (+322.16%).
- NBIX annual EBITDA is now at all-time high.
Performance
NBIX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$152.90M+$121.60M(+388.50%)Summary
- As of today, NBIX quarterly EBITDA is $152.90 million, with the most recent change of +$121.60 million (+388.50%) on June 30, 2025.
- Over the past year, NBIX quarterly EBITDA has dropped by -$2.30 million (-1.48%).
- NBIX quarterly EBITDA is now -20.07% below its all-time high of $191.30 million, reached on September 30, 2024.
Performance
NBIX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$557.20M-$2.30M(-0.41%)Summary
- As of today, NBIX TTM EBITDA is $557.20 million, with the most recent change of -$2.30 million (-0.41%) on June 30, 2025.
- Over the past year, NBIX TTM EBITDA has dropped by -$12.20 million (-2.14%).
- NBIX TTM EBITDA is now -12.90% below its all-time high of $639.70 million, reached on December 31, 2024.
Performance
NBIX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NBIX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +62.9% | -1.5% | -2.1% |
| 3Y3 Years | +322.2% | +989.0% | +1116.6% |
| 5Y5 Years | +578.7% | +63.4% | +283.8% |
NBIX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +322.2% | -20.1% | +257.3% | -12.9% | +411.2% |
| 5Y | 5-Year | at high | +578.7% | -20.1% | +257.3% | -12.9% | +1116.6% |
| All-Time | All-Time | at high | +387.4% | -20.1% | +220.9% | -12.9% | +361.4% |
NBIX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $152.90M(+388.5%) | $557.20M(-0.4%) |
| Mar 2025 | - | $31.30M(-82.8%) | $559.50M(-12.5%) |
| Dec 2024 | $583.00M(+62.8%) | $181.70M(-5.0%) | $639.70M(+4.2%) |
| Sep 2024 | - | $191.30M(+23.3%) | $614.00M(+7.8%) |
| Jun 2024 | - | $155.20M(+39.2%) | $569.40M(+15.5%) |
| Mar 2024 | - | $111.50M(-28.5%) | $492.90M(+73.4%) |
| Dec 2023 | $358.00M(+51.3%) | $156.00M(+6.3%) | $284.20M(+1.6%) |
| Sep 2023 | - | $146.70M(+86.4%) | $279.60M(+18.5%) |
| Jun 2023 | - | $78.70M(+181.0%) | $236.00M(+68.5%) |
| Mar 2023 | - | -$97.20M(-164.2%) | $140.10M(-47.1%) |
| Dec 2022 | $236.60M(+71.3%) | $151.40M(+46.8%) | $264.60M(+142.8%) |
| Sep 2022 | - | $103.10M(+699.4%) | $109.00M(+138.0%) |
| Jun 2022 | - | -$17.20M(-163.0%) | $45.80M(-64.6%) |
| Mar 2022 | - | $27.30M(+750.0%) | $129.30M(-6.4%) |
| Dec 2021 | $138.10M(-6.8%) | -$4.20M(-110.5%) | $138.10M(-28.8%) |
| Sep 2021 | - | $39.90M(-39.8%) | $194.00M(+80.1%) |
| Jun 2021 | - | $66.30M(+83.7%) | $107.70M(-20.2%) |
| Mar 2021 | - | $36.10M(-30.2%) | $135.00M(-8.8%) |
| Dec 2020 | $148.10M(+72.4%) | $51.70M(+211.4%) | $148.10M(+2.0%) |
| Sep 2020 | - | -$46.40M(-149.6%) | $145.20M(-44.2%) |
| Jun 2020 | - | $93.60M(+90.2%) | $260.00M(+13.9%) |
| Mar 2020 | - | $49.20M(+0.8%) | $228.20M(+165.7%) |
| Dec 2019 | $85.90M(+52.6%) | $48.80M(-28.7%) | $85.90M(+32.5%) |
| Sep 2019 | - | $68.40M(+10.7%) | $64.85M(+15.9%) |
| Jun 2019 | - | $61.80M(+166.4%) | $55.97M(+1810.5%) |
| Mar 2019 | - | -$93.10M(-435.5%) | -$3.27M(-105.8%) |
| Dec 2018 | $56.30M(+146.7%) | $27.75M(-53.4%) | $56.30M(+29.2%) |
| Sep 2018 | - | $59.52M(+2223.9%) | $43.57M(+327.9%) |
| Jun 2018 | - | $2.56M(+107.6%) | -$19.12M(+74.9%) |
| Mar 2018 | - | -$33.53M(-323.2%) | -$76.31M(+36.7%) |
| Dec 2017 | -$120.62M(+13.6%) | $15.02M(+573.5%) | -$120.62M(+32.9%) |
| Sep 2017 | - | -$3.17M(+94.2%) | -$179.85M(+15.6%) |
| Jun 2017 | - | -$54.63M(+29.8%) | -$213.16M(-7.4%) |
| Mar 2017 | - | -$77.84M(-76.0%) | -$198.49M(-40.5%) |
| Dec 2016 | -$139.64M(-58.8%) | -$44.21M(-21.2%) | -$141.23M(-15.6%) |
| Sep 2016 | - | -$36.48M(+8.7%) | -$122.22M(-0.7%) |
| Jun 2016 | - | -$39.96M(-94.1%) | -$121.34M(-14.0%) |
| Mar 2016 | - | -$20.58M(+18.3%) | -$106.46M(-21.1%) |
| Dec 2015 | -$87.92M(-38.3%) | -$25.20M(+29.2%) | -$87.92M(-6.0%) |
| Sep 2015 | - | -$35.60M(-42.0%) | -$82.96M(-29.6%) |
| Jun 2015 | - | -$25.07M(-1126.6%) | -$64.00M(-20.6%) |
| Mar 2015 | - | -$2.04M(+89.9%) | -$53.08M(+16.5%) |
| Dec 2014 | -$63.58M(-29.7%) | -$20.24M(-21.7%) | -$63.58M(-16.2%) |
| Sep 2014 | - | -$16.64M(-17.6%) | -$54.71M(-9.6%) |
| Jun 2014 | - | -$14.15M(-12.8%) | -$49.91M(-2.4%) |
| Mar 2014 | - | -$12.55M(-10.3%) | -$48.75M(+0.5%) |
| Dec 2013 | -$49.01M(-2428.1%) | -$11.37M(+3.9%) | -$49.01M(-69.7%) |
| Sep 2013 | - | -$11.84M(+8.9%) | -$28.88M(-38.6%) |
| Jun 2013 | - | -$12.99M(-1.5%) | -$20.84M(-130.1%) |
| Mar 2013 | - | -$12.80M(-246.2%) | -$9.05M(-530.2%) |
| Dec 2012 | $2.10M(-93.9%) | $8.76M(+330.5%) | $2.10M(+134.7%) |
| Sep 2012 | - | -$3.80M(-212.9%) | -$6.06M(-121.4%) |
| Jun 2012 | - | -$1.21M(+26.0%) | $28.31M(-8.1%) |
| Mar 2012 | - | -$1.64M(-378.4%) | $30.80M(-11.0%) |
| Dec 2011 | $34.62M(+381.8%) | $589.00K(-98.1%) | $34.62M(+1.2%) |
| Sep 2011 | - | $30.58M(+2307.7%) | $34.20M(+431.6%) |
| Jun 2011 | - | $1.27M(-41.7%) | $6.43M(+1857.9%) |
| Mar 2011 | - | $2.18M(+1138.1%) | -$366.00K(+97.0%) |
| Dec 2010 | -$12.29M | $176.00K(-93.7%) | -$12.29M(+49.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $2.81M(+150.8%) | -$24.17M(+32.6%) |
| Jun 2010 | - | -$5.53M(+43.2%) | -$35.86M(+19.1%) |
| Mar 2010 | - | -$9.74M(+16.8%) | -$44.35M(+7.5%) |
| Dec 2009 | -$47.93M(+35.2%) | -$11.71M(-32.0%) | -$47.93M(+19.6%) |
| Sep 2009 | - | -$8.88M(+36.7%) | -$59.66M(+7.5%) |
| Jun 2009 | - | -$14.02M(-5.2%) | -$64.51M(+6.0%) |
| Mar 2009 | - | -$13.33M(+43.1%) | -$68.61M(+7.3%) |
| Dec 2008 | -$73.98M(+63.5%) | -$23.43M(-70.6%) | -$73.98M(+58.2%) |
| Sep 2008 | - | -$13.73M(+24.2%) | -$176.97M(+6.8%) |
| Jun 2008 | - | -$18.12M(+3.1%) | -$189.85M(+3.5%) |
| Mar 2008 | - | -$18.70M(+85.2%) | -$196.82M(+3.0%) |
| Dec 2007 | -$202.84M(-97.4%) | -$126.43M(-375.0%) | -$202.84M(-125.1%) |
| Sep 2007 | - | -$26.61M(-6.1%) | -$90.09M(+10.8%) |
| Jun 2007 | - | -$25.08M(-1.5%) | -$101.04M(+1.5%) |
| Mar 2007 | - | -$24.71M(-80.6%) | -$102.54M(+0.2%) |
| Dec 2006 | -$102.75M(-586.0%) | -$13.68M(+63.6%) | -$102.75M(+7.5%) |
| Sep 2006 | - | -$37.56M(-41.4%) | -$111.06M(-142.3%) |
| Jun 2006 | - | -$26.57M(-6.6%) | -$45.83M(-99.2%) |
| Mar 2006 | - | -$24.93M(-13.4%) | -$23.00M(-53.6%) |
| Dec 2005 | -$14.98M(+66.9%) | -$21.99M(-179.5%) | -$14.98M(-25.9%) |
| Sep 2005 | - | $27.66M(+838.3%) | -$11.89M(+70.6%) |
| Jun 2005 | - | -$3.75M(+77.8%) | -$40.50M(+16.8%) |
| Mar 2005 | - | -$16.91M(+10.6%) | -$48.67M(-7.6%) |
| Dec 2004 | -$45.25M(+17.9%) | -$18.91M(-1913.4%) | -$45.25M(-5.4%) |
| Sep 2004 | - | -$939.00K(+92.1%) | -$42.92M(+21.3%) |
| Jun 2004 | - | -$11.92M(+11.6%) | -$54.54M(-0.8%) |
| Mar 2004 | - | -$13.49M(+18.6%) | -$54.10M(+1.8%) |
| Dec 2003 | -$55.09M(+45.2%) | -$16.57M(-32.0%) | -$55.09M(+30.2%) |
| Sep 2003 | - | -$12.56M(-9.4%) | -$78.89M(+10.4%) |
| Jun 2003 | - | -$11.48M(+20.7%) | -$88.05M(+10.0%) |
| Mar 2003 | - | -$14.49M(+64.1%) | -$97.88M(+2.6%) |
| Dec 2002 | -$100.52M(-143.8%) | -$40.36M(-85.9%) | -$100.52M(-34.3%) |
| Sep 2002 | - | -$21.72M(-1.9%) | -$74.83M(-46.1%) |
| Jun 2002 | - | -$21.32M(-24.5%) | -$51.23M(-14.2%) |
| Mar 2002 | - | -$17.12M(-16.7%) | -$44.87M(-8.8%) |
| Dec 2001 | -$41.23M(-23.4%) | -$14.67M(-880.4%) | -$41.23M(-10.6%) |
| Sep 2001 | - | $1.88M(+112.6%) | -$37.29M(+22.8%) |
| Jun 2001 | - | -$14.95M(-10.9%) | -$48.29M(-20.2%) |
| Mar 2001 | - | -$13.49M(-25.7%) | -$40.18M(-20.3%) |
| Dec 2000 | -$33.40M(-87.7%) | -$10.73M(-17.6%) | -$33.40M(-23.4%) |
| Sep 2000 | - | -$9.12M(-33.3%) | -$27.07M(-20.6%) |
| Jun 2000 | - | -$6.84M(-2.0%) | -$22.45M(-9.5%) |
| Mar 2000 | - | -$6.71M(-52.4%) | -$20.50M(-15.9%) |
| Dec 1999 | -$17.80M(-66.4%) | -$4.40M(+2.2%) | -$17.69M(-6.6%) |
| Sep 1999 | - | -$4.50M(+8.0%) | -$16.59M(-12.9%) |
| Jun 1999 | - | -$4.89M(-25.4%) | -$14.69M(-14.8%) |
| Mar 1999 | - | -$3.90M(-18.2%) | -$12.80M(-17.4%) |
| Dec 1998 | -$10.70M(-694.4%) | -$3.30M(-26.9%) | -$10.90M(-28.2%) |
| Sep 1998 | - | -$2.60M(+13.3%) | -$8.50M(-41.7%) |
| Jun 1998 | - | -$3.00M(-50.0%) | -$6.00M(-71.4%) |
| Mar 1998 | - | -$2.00M(-122.2%) | -$3.50M(-284.2%) |
| Dec 1997 | $1.80M(-53.8%) | -$900.00K(-800.0%) | $1.90M(-70.3%) |
| Sep 1997 | - | -$100.00K(+80.0%) | $6.40M(+20.8%) |
| Jun 1997 | - | -$500.00K(-114.7%) | $5.30M(-27.4%) |
| Mar 1997 | - | $3.40M(-5.6%) | $7.30M(+87.2%) |
| Dec 1996 | $3.90M | $3.60M(+400.0%) | $3.90M(+1200.0%) |
| Sep 1996 | - | -$1.20M(-180.0%) | $300.00K(-80.0%) |
| Jun 1996 | - | $1.50M(>+9900.0%) | $1.50M(>+9900.0%) |
| Mar 1996 | - | $0.00 | $0.00 |
FAQ
- What is Neurocrine Biosciences, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. annual EBITDA year-on-year change?
- What is Neurocrine Biosciences, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. quarterly EBITDA year-on-year change?
- What is Neurocrine Biosciences, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. TTM EBITDA year-on-year change?
What is Neurocrine Biosciences, Inc. annual EBITDA?
The current annual EBITDA of NBIX is $583.00M
What is the all-time high annual EBITDA for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high annual EBITDA is $583.00M
What is Neurocrine Biosciences, Inc. annual EBITDA year-on-year change?
Over the past year, NBIX annual EBITDA has changed by +$225.00M (+62.85%)
What is Neurocrine Biosciences, Inc. quarterly EBITDA?
The current quarterly EBITDA of NBIX is $152.90M
What is the all-time high quarterly EBITDA for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high quarterly EBITDA is $191.30M
What is Neurocrine Biosciences, Inc. quarterly EBITDA year-on-year change?
Over the past year, NBIX quarterly EBITDA has changed by -$2.30M (-1.48%)
What is Neurocrine Biosciences, Inc. TTM EBITDA?
The current TTM EBITDA of NBIX is $557.20M
What is the all-time high TTM EBITDA for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high TTM EBITDA is $639.70M
What is Neurocrine Biosciences, Inc. TTM EBITDA year-on-year change?
Over the past year, NBIX TTM EBITDA has changed by -$12.20M (-2.14%)